Nektar Therapeutics (NKTR)

Nektar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	42.99	44.25	35.28	88.23	25.22	198.96
Short-Term Investments	132.92	210.97	268.34	416.75	708.74	862.94
Cash & Short-Term Investments	175.9	255.23	303.62	504.98	733.96	1,062
Cash Growth	-35.15%	-15.94%	-39.88%	-31.20%	-30.88%	-19.85%
Accounts Receivable	-	-	1.21	5.98	22.49	38.89
Other Receivables	-	1.61	1.05	2.42	1.4	5.1
Receivables	-	1.61	2.25	8.4	23.89	43.99
Inventory	-	-	16.1	19.2	15.8	15.29
Prepaid Expenses	-	2.51	4.41	5.99	-	-
Other Current Assets	10.66	1.95	4.33	7.4	21.93	16.83
Total Current Assets	186.57	261.29	330.7	545.97	795.58	1,138
Property, Plant & Equipment	10.57	11.82	36.86	85.89	177.54	186.14
Long-Term Investments	5.37	26.09	25.83	-	64.83	136.66
Goodwill	-	-	-	76.5	76.5	76.5
Other Long-Term Assets	5.02	4.65	4.64	2.25	2.74	1.46
Total Assets	207.53	303.85	398.03	710.6	1,117	1,539
Accounts Payable	14.28	11.56	9.85	12.98	9.75	22.14
Accrued Expenses	35.1	27.21	19.14	28.85	58.01	79.73
Current Portion of Leases	22.01	19.87	19.26	18.67	17.44	13.92
Other Current Liabilities	-	2.77	3.02	7.71	-	-
Total Current Liabilities	71.39	61.4	51.27	68.2	85.2	115.78
Long-Term Debt	80.57	91.78	112.63	155.38	195.43	200.34
Long-Term Leases	74.15	82.7	98.52	112.83	125.74	136.37
Other Long-Term Liabilities	5.64	7.24	4.64	7.55	31.32	8.98
Total Liabilities	231.75	243.11	267.05	343.96	437.68	461.47
Common Stock	0	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	3,667	3,660	3,608	3,575	3,517	3,389
Retained Earnings	-3,689	-3,596	-3,477	-3,201	-2,833	-2,309
Treasury Stock	-3	-3	-	-	-	-
Comprehensive Income & Other	-0.01	0.06	0.08	-6.91	-4.16	-2.3
Shareholders' Equity	-24.21	60.74	130.99	366.64	679.51	1,077
Total Liabilities & Equity	207.53	303.85	398.03	710.6	1,117	1,539
Total Debt	176.73	194.34	230.4	286.87	338.6	350.63
Net Cash (Debt)	-0.83	74.76	99.04	218.1	460.18	847.93
Net Cash Growth	-	-24.52%	-54.59%	-52.61%	-45.73%	-24.55%
Net Cash Per Share	-0.06	5.45	7.82	17.48	37.66	71.22
Filing Date Shares Outstanding	14.09	12.41	12.24	12.62	12.42	12.15
Total Common Shares Outstanding	14.09	12.39	12.76	12.57	12.36	12.01
Working Capital	115.18	199.89	279.43	477.76	710.38	1,022
Book Value Per Share	-1.72	4.90	10.27	29.17	54.96	89.73
Tangible Book Value	-24.21	60.74	130.99	290.14	603.01	1,001
Tangible Book Value Per Share	-1.72	4.90	10.27	23.08	48.77	83.36
Buildings	-	3.88	43.18	74.89	97.39	92.98
Machinery	-	15.2	61.83	79.76	104	100.47
Construction In Progress	-	0.25	0.74	2.53	7.16	4.7

Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q